These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23346000)

  • 1. Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions.
    Seok H; Lee EY; Choe EY; Yang WI; Kim JY; Shin DY; Cho HJ; Kim TS; Yun MJ; Lee JD; Lee EJ; Lim SK; Rhee Y
    Korean J Intern Med; 2013 Jan; 28(1):81-8. PubMed ID: 23346000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
    Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
    J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study.
    Jeong SY; Lee SW; Lee HJ; Kang S; Seo JH; Chun KA; Cho IH; Won KS; Zeon SK; Ahn BC; Lee J
    Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2334-43. PubMed ID: 20661556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas.
    Feng Z; He D; Mao Z; Wang Z; Zhu Y; Zhang X; Wang H
    Clin Nucl Med; 2016 Mar; 41(3):e130-4. PubMed ID: 26646998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Evaluation of Sellar and Parasellar Macrolesions by [
    Tosaka M; Higuchi T; Horiguchi K; Osawa T; Arisaka Y; Fujita H; Tsushima Y; Yoshimoto Y
    World Neurosurg; 2017 Jul; 103():591-599. PubMed ID: 28427982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of
    Wang Z; Mao Z; Zhang X; He D; Wang X; Du Q; Xiao Z; Zhu D; Zhu Y; Wang H
    Acad Radiol; 2019 Sep; 26(9):1222-1228. PubMed ID: 30318288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study.
    Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z
    J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of combination [
    Wang Z; Feng Z; Zhu D; Wang X; Chen J; Zhu Y; Wang H
    BMC Endocr Disord; 2024 Feb; 24(1):19. PubMed ID: 38311763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenomas can appear as hypermetabolic lesions in (18) F-FDG PET imaging.
    Ryu SI; Tafti BA; Skirboll SL
    J Neuroimaging; 2010 Oct; 20(4):393-6. PubMed ID: 19453834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRH stimulation improves
    Boyle J; Patronas NJ; Smirniotopoulos J; Herscovitch P; Dieckman W; Millo C; Maric D; Chatain GP; Hayes CP; Benzo S; Scott G; Edwards N; Ray Chaudhury A; Lodish MB; Sharma S; Nieman LK; Stratakis CA; Lonser RR; Chittiboina P
    Endocrine; 2019 Jul; 65(1):155-165. PubMed ID: 31062234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pituitary in nuclear medicine imaging.
    Iglesias P; Cardona J; Díez JJ
    Eur J Intern Med; 2019 Oct; 68():6-12. PubMed ID: 31519379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria.
    Hyun SH; Choi JY; Lee KH; Choe YS; Kim BT
    J Nucl Med; 2011 Apr; 52(4):547-50. PubMed ID: 21421711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone suppression for
    Kim K; Kim DK; Moon JH; Kim EH; Kim SH; Ku CR; Lee EJ
    Cancer Imaging; 2023 Sep; 23(1):85. PubMed ID: 37700359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
    Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy.
    Zhao X; Xiao J; Xing B; Wang R; Zhu Z; Li F
    Clin Nucl Med; 2014 Jul; 39(7):605-8. PubMed ID: 24873787
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
    J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.